Baxter 2021 Corporate Responsibility Report 15 Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Corporate Responsibility Commitment Introduction 2030 Corporate Responsibility Goals Cross-Cutting Commitments Reach More Underserved Kidney Patients 2030 CORPORATE RESPONSIBILITY GOAL : Double the number of patients reached in underserved markets* through our peritoneal dialysis (PD) portfolio. * Countries outside of the United States, Canada, Western Europe, Japan, Korea, Australia and New Zealand. (Baseline: 198,000 patients in 2020) PERFORMANCE: In 2021, we reached more than 204,000 patients in underserved markets through our PD portfolio. Given the number of barriers to care in these markets, we are taking a staged approach—beginning with awareness and education—that we intend to accelerate in future years. APPROACH AND PROGRESS Increasing access to Baxter’s lifesaving products for patients and caregivers globally is one of our company’s top priorities. Our 2030 goal to reach more kidney patients in developing countries emphasizes the importance of supporting this underserved population. People in developing countries are at a higher risk of developing kidney disease and have less opportunity to access the life-sustaining therapy needed to survive the disease. Though estimations vary, it is believed that up to nearly 10 million people worldwide require renal therapy, yet fewer than 3 million people receive treatment. 1 Home-based PD offers patients the opportunity to manage their therapy at home, provides equal or better outcomes for many and is often less costly when compared with clinic-based hemodialysis. PD also provides patients, who have immune dysfunction, an opportunity to socially distance themselves to reduce the risk of viral infections, such as COVID-19. In 2021, we focused on the following programs and activities as we began laying the foundation to increase access to PD in developing countries. Hosted second International Home Dialysis Roundtable Sponsored hands-on PD catheter training for nearly 400 nephrologists from 19 countries 50,000+ patients in 70 countries connected to their clinicians via Sharesource APPROACH TO REACHING RENAL PATIENTS IN UNDERSERVED MARKETS We are taking a three-pronged approach to reach our 2030 goal. Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Corporate Responsibility Commitment Introduction 2030 Corporate Responsibility Goals Cross-Cutting Commitments Driving Shared Decision Making Choosing an appropriate therapy option is an important decision for people with chronic kidney disease. Patients must be aware of and informed about their options so they can advocate for the treatment choice that is best for them. Engagement between trusted and informed clinicians and patients is critical to increasing patients’ awareness of treatment options and accelerating the adoption of PD. In 2021, Baxter launched a campaign to raise clinician and patient awareness about the benefits of PD so they can have more informed discussions about therapy options. Driving Shared Decision Making Advocating for Access to PD Expanding Innovation and Services